SCOPUS 정보 검색 플랫폼

Investigational New Drugs

Volumn 18, Issue 4, 2000, Pages 383-390

Clinical development of eniluracil/fluorouracil: An oral treatment for patients with solid tumors

(2) Levin, Jeremey a Hohneker, John a

a GLAXOSMITHKLINE (United States)

Author keywords

5 Fluorouracil; 776C85; Dehydrogenase; Dihydropyrimidine oral therapy; Eniluracil

Indexed keywords

5 ETHYNYLURACIL; ANTINEOPLASTIC AGENT; CAPECITABINE; DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID;

BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COLORECTAL CANCER; DRUG INDUCED DISEASE; DRUG SAFETY; ENZYME INACTIVATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SOLID TUMOR;

ADMINISTRATION, ORAL; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS; DRUG SYNERGISM; ENZYME INHIBITORS; FLUOROURACIL; HUMAN; NEOPLASMS; URACIL;

EID: 0033770384 PISSN: 01676997 EISSN: None Source Type: Journal
DOI: 10.1023/A:1006457617467 Document Type: Review

Times cited : (6)

References (31)

1
- 0027489763
- (1993) Proc Natl Acad Sci , vol.90 , pp. 11064-11068
- Baccanari, D.P.¹ Davis, S.T.² Knick, V.C.³ Spector, T.⁴

2
- 0028920324
- Attenuation of the antitumor acticity of 5-fluorouracil by (R)-fluoro-5,6-dihydrouracil
- (1995) Canc Res , vol.55 , pp. 123-1241
- Spector, T.¹ Cao, S.² Rustum, Y.M.³ Harrington, J.A.⁴ Porter, D.J.T.⁵

3
- 0028982820
- Response to fluorouracil therapy in cancer patients. The role of tumoral dihydropyrimidine dehydrogenase activity
- (1995) J Clin Oncol , vol.13 , pp. 1663-1670
- Etienne, M.C.¹ Cheradame, S.² Fischel, J.L.³ Formento, P.⁴ Dassonville, I.⁵ Renee, M.⁶ Schneider, M.⁷ Thyss, A.⁸ Demard, F.⁹ Milano, G.¹⁰

4
- 0024347268
- Biochemical Modulation of Fluorouracil: Evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma
- (1989) J Clin Oncol , vol.7 , pp. 1407-1418
- Poon, M.A.¹ O'Connell, M.J.² Moertel, C.G.³ Weiand, J.S.⁴ Cullinan, S.A.⁵ Everson, L.K.⁶ Krook, J.E.⁷ Mailliard, J.A.⁸ Laurie, J.A.⁹ Tschetter, L.K.¹⁰ Wiesenfeld, M.¹¹

5
- 10544243363
- Pharmacokinetic, oral bioavailability, and safety study of fluorouracil in patients treated with 776C85, an inactivator of dihydropyrimidine dehydrogenase
- (1996) J Clin Oncol , vol.14 , pp. 3085-3096
- Baker, S.D.¹ Khor, S.P.² Adjei, A.A.³ Doucette, M.⁴ Spector, T.⁵ Donehower, R.C.⁶ Grochow, L.B.⁷ Sartorlus, S.E.⁸ Noe, D.A.⁹ Hohneker, J.A.¹⁰ Rowinsky, E.K.¹¹

6
- 0002548405
- 5-Fluoropyrimidines
- Chabner BA, Longo DL (eds) Cancer Chemotherapy and Biotherapy: Principles and Practice (ed 2). Lippincott Raven, Philadelphia, PA
- (1996) , pp. 149-217
- Grem, J.L.¹

7
- 0027524408
- Clinical pharmacokinetics of 5-fluorouracil. Clinical pharmacokinetics of 5-fluorouracil: Influence of the biomodulating agents interferon, dipyridamole, and folinic acid alone and in combination
- (1993) Arzneirnittel-Forschung/Drug Res , vol.43 , pp. 387-390
- Czejka, M.J.¹ Jager, W.² Schuller, J.³ Fogl, U.⁴ Weiss, C.⁵ Schernthaner, G.⁶

8
- 0031900670
- Phase I clinical and pharmacologic study of eniluracil plus fluorouracil in patients with advanced cancer
- (1998) J Clin Oncol , vol.49 , pp. 1450-1457
- Schilsky, R.L.¹ Hohneker, J.² Ratain, M.J.³ Janisch, L.⁴ Smetzer, L.⁵ Lucas, V.S.⁶ Khor, S.P.⁷ Diasio, R.⁸ Van Hoff, D.D.⁹ Burris, H.A.¹⁰

9
- 0023218328
- Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5FU) in colorectal cancer patients
- (1987) Eur J Clin Pharmacol , vol.32 , pp. 411-418
- Schaaf, L.J.¹ Dobbs, B.R.² Edwards, I.R.³ Perrier, D.G.⁴

10
- 0028357629
- Relationship between fluorouracil systemic exposure and tumor response and patient survival
- (1994) J Clin Oncol , vol.12 , pp. 1291-1295
- Milano, G.¹ Etienne, M.C.² Renee, N.³ Thyss, A.⁴ Schneider, M.⁵ Ramaioli, A.⁶ Demard⁷

11
- 0000560334
- Phase I and Pharmacologic Study of oral 5-Fluorouracil (5-FU) on a chronic 28-day schedule in combination with the Dihydropyrimidine Dehydrogenase (DPD) Inactivator 776C85
- (1996) Proc ASCO , vol.15 , pp. 486
- Baker, S.D.¹ Diasio, R.² Lucas, V.S.³ Khor, S.-P.⁴ Thomas, S.⁵ Sartorius, S.⁶ Donehower, R.⁷ Eisenherger, M.⁸ Grochow, L.⁹ O'Reilly, S.¹⁰ Hohneker, J.¹¹ Rowinsky, E.¹²

12
- 0025058867
- Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion
- (1990) Cancer Res , vol.50 , pp. 197-201
- Harris, B.E.¹ Song, R.² Soong, S.³ Diasio, R.⁴

13
- 0344109583
- Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer
- (1998) J Clin Oncol , vol.16 , pp. 301-308
- Piedbois, P.¹ Rougier, P.² Buyse, M.³ Pignon, J.P.⁴ Ryan, L.⁵ Hansen, R.⁶ Zee, B.⁷ Weinerman, B.⁸ Pater, J.⁹ Leichman, C.¹⁰ MacDonald, J.¹¹ Benedetti, J.¹² Lokich, J.¹³ Fryer, J.¹⁴ Brufman, G.¹⁵ Isacson, R.¹⁶ Laplanche, A.¹⁷ Levy, E.¹⁸

14
- 0024539308
- A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: A mid-Atlantic oncology program study
- (1989) J Clin Oncol , vol.7 , pp. 425-432
- Lokich, J.J.¹ Ahlgren, J.D.² Gullo, J.J.³ Philips, J.A.⁴ Fryer, J.G.⁵

15
- 0001241548
- Eniluracil treatment completely inactivated dihydropyrimidine dehydrogenase activity in colorectal tumors
- (1999) Proc ASCO , vol.18
- McLeod, H.L.¹ Armed, F.Y.² Johnston, S.J.³ O'Kelly, T.⁴ Binnie, N.⁵ Murray, G.I.⁶ Van Gennip, A.H.⁷ Abeling, N.G.G.M.⁸ Knight, S.⁹ Cassidy, J.¹⁰

16
- 0000419698
- A Phase II Open-Label Study to evaluate a 28-day regimen of oral 5-fluorouracil (5-FU) plus 776C85 for the treatment of patients with previously untreated metastatic colorectal cancer (CRC)
- (1998) Proc ASCO , vol.17
- Mani, S.¹ Beck, T.² Chevlen, E.³ Hochster, H.⁴ O'Rourke, M.⁵ Weaver, C.⁶ Bell, W.⁷ MeGuirt, C.⁸ Levin, J.⁹ Hohneker, J.¹⁰ Lokich, J.¹¹

17
- 0000513126
- A phase II study of a rive day regimen of oral 5-fluorouracil (5-FU) plus GW776 (776C85) with or without leucovorin in patients with metastatic colorectal cancer
- (1997) Proc ASCO , vol.16
- Schilsky, R.¹ Bukowski, R.² Burris, H.³ Crawford, J.⁴ Hochster, H.⁵ O'Rourke, M.⁶ Steinfeldt, H.⁷ Doucette, M.⁸ Levin, J.⁹ Hohneker, J.¹⁰

18
- 0003214185
- A Phase II trial of a seven day regimen of oral 776C85 plus a five day regimen of oral 5-fluorouracil (5-FU) in untreated patients (PTS) with Metastatic Colorectal Cancer (M-CRC): A North Central Cancer Treatment Group Study
- (1998) Proc ASCO , vol.17
- Goldberg, R.M.¹ Kugler, J.² Sargent, D.J.³ Malioney, M.R.⁴

19
- 0029860378
- Low-dose continuous intravenous infusion of 5-fluorouracil for metastatic breast cancer
- (1996) Ann Oncol , vol.7 , pp. 807-813
- Regazzoni, S.¹ Pesce, G.² Marini, G.³ Cavalli, F.⁴ Goldhirsch, A.⁵

20
- 0024532587
- Low-dose continuous infusion 5-fluorouracil. Evaluation in advanced breast carcinoma
- (1989) Cancer , vol.63 , pp. 419-422
- Huan, S.¹ Pazdur, R.² Singhakowinta, A.³ Samal, B.⁴ Vaitkevicius, V.K.⁵

21
- 0003229177
- A phase II open label study to evaluate a 28-day oral regimen of 5-fluorouracil (5-FU) plus 776C85 for the treatment of patients with taxane and anthracycline resistant advanced breast cancer: Preliminary results
- (1998) Proc ASCO , vol.17
- Rivera, E.¹ Chevlen, E.² Eckardt, J.³ Kennedy, M.J.⁴ Sawhney, R.⁵ Sutton, L.⁶ Frye, D.⁷ Hedrick, J.⁸ McGuirt, C.⁹ Levin, J.¹⁰ Hohneker, J.¹¹ Hortobagyi, G.N.¹²

22
- 0000330958
- Eniluracil/5FU in anthracycline and taxane refractory breast cancer
- (1999) Proc ASCO , vol.18 , pp. 405
- Burns, H.A.¹ Ravdin, P.² Guthell, J.³ Shepard, R.⁴ Rivera, E.⁵ MeGuirt, C.⁶ Levin, J.⁷ Decker, J.⁸ Hohneker, J.⁹ Winer, E.¹⁰

23
- 0000212332
- 2 x 2 daily) as first-line chemotherapy in patients with advanced breast cancer: A phase II study
- (1999) Proc ASCO , vol.18 , pp. 402
- Smith, I.¹ Johnston, S.² O'Brien, M.³ Hickish, T.⁴ Harris, D.⁵ Barton, C.⁶

24
- 4243654941
- Phase II study of eniluracil (776C85) and oral 5-fluorouracil (5-FU) in patients with advanced squamous cell head and neck cancer (HNC)
- (1999) Proc ASCO , vol.18
- Knowling, M.¹ Browman, G.² Cooke, A.³ Siu, L.⁴ Seymous, L.⁵ Cripps, C.⁶ Matthews, S.⁷ Rodgers, A.⁸

25
- 0026569931
- A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck
- (1992) J Clin Oncol , vol.10 , pp. 257-263
- Jacobs, C.¹ Lyman, G.² Velez-Garels, E.³ Sridhar, K.S.⁴ Knight, W.⁵ Hochster, H.⁶ Goodnough, L.T.⁷ Mortimer, J.E.⁸ Einhorn, L.H.⁹ Schacter, L.¹⁰ Cherng, H.¹¹ Dalton, R.¹² Burroughs, J.¹³ Rozencweig, M.¹⁴

26
- 0033049035
- Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer
- (1999) Clin Cancer Res , vol.5 , pp. 291-298
- Humerickhouse, R.A.¹ Dolan, M.E.² Haraf, D.J.³ Brockstein, B.⁴ Stenson, K.⁵ Kies, M.⁶ Sulzen, L.⁷ Ratain, M.J.⁸ Vokes, E.E.⁹

27
- 0003306380
- Promising early results of oral 5-fluorouracil plus eniluracil (776C85) in patients with advanced adenocarcinoma of the pancreas
- (1998) Ann of Oncol , vol.9 , pp. 46
- Wilki, N.¹ Glimelius, B.² Schueller, J.³ Van Laethem, J.L.⁴ Figer, A.⁵ Barton, C.⁶ Silveira, C.⁷

28
- 0000390717
- A multicenter, phase II trial of oral eniluracil plus 5-FU in patients with inoperable hepatocellular carcinoma
- (1999) Proc ASCO , vol.18 , pp. 985
- Benson, A.B.¹ Mitchell, E.² Abramson, N.³ Klenke, B.⁴ Ritch, P.⁵ Burnham, J.⁶ McGuirt, C.⁷ Levin, J.⁸ Hohneker, J.⁹

29
- 0030988930
- Dihydropyrimidine dehydrogenase activity in hepatocellular carcinoma: Implication in 5-fluorouracil-based chemotherapy
- (1997) Clin Cancer Res , vol.3 , pp. 395-399
- Jiang, W.¹ Lu, Z.² He, Y.³ Diasio, R.B.⁴

30
- 0345596364
- Toxicity of fluorouracil in patients with advanced colorectal cancer: Effect of administration schedule and prognostic factors
- (1998) J Clin Oncol , vol.16 , pp. 3537-3541

31
- 0033050165
- Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer
- (1999) J Clin Oncol , vol.17 , pp. 485-493
- Blum, J.L.¹ Jones, S.E.² Buzdar, A.U.³ LoRusso, P.M.⁴ Kuter, I.⁵ Vogel, C.⁶ Osterwalder, B.⁷ Burger, H.U.⁸ Brown, C.S.⁹ Griffin, T.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.